RhyGaze AG

RhyGaze AG is focused on gene therapy for vision restoration, utilizing optogenetic proteins and gene therapy tools to restore sight for individuals with vision loss due to retinal diseases

rhygaze.com

Biotech & Life Sciences

Sector

Seed

Stage

Biotechnology

Model

01Company Overview

RhyGaze AG is focused on gene therapy for vision restoration, utilizing optogenetic proteins and gene therapy tools to restore sight for individuals with vision loss due to retinal diseases.

02Backed By1 investor

AVARCH Venture Partners→

03Similar Companies